文献速递胸部肿瘤

癌症-免疫循环免疫图:面向肺癌的个体化免疫治疗

An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2017-01-11

研究对20例非小细胞肺癌患者(12例腺癌、7例鳞状细胞癌、1例大细胞神经内分泌癌)进行全外显子测序和RNA测序,评估突变新抗原和癌种系抗原与患者人类白细胞抗原分子的预测结合,并构建反映癌症-免疫循环七个步骤的八轴雷达图免疫图。观察到T细胞丰富型、T细胞贫乏型和中间型三种免疫图模式,腺癌与非腺癌患者均包含T细胞丰富型和T细胞贫乏型,提示组织学类型不一定反映肿瘤的癌症免疫状态。作者认为免疫图作为整合生物标志物可呈现患者特异性肿瘤微环境景观,可能成为优化个体化免疫治疗的有价值资源。

要点

  • 在20例非小细胞肺癌患者中构建了基于测序的癌症-免疫循环免疫图。
  • 观察到T细胞丰富型、T细胞贫乏型和中间型三种免疫图模式。
  • 腺癌与非腺癌患者均包含T细胞丰富型和T细胞贫乏型。

核心结论

  • 利用免疫图作为整合生物标志物可呈现患者特异性肿瘤微环境景观,可能成为优化个体化免疫治疗的有价值资源。

研究设计与样本

  • 对20例非小细胞肺癌患者(12例腺癌、7例鳞状细胞癌、1例大细胞神经内分泌癌)进行全外显子测序和RNA测序。
  • 评估肿瘤中表达的突变新抗原和癌种系抗原与患者人类白细胞抗原分子的预测结合。
  • 评估癌症免疫相关基因表达并标准化,构建反映癌症-免疫循环七个步骤的八轴雷达图。

主要发现

  • 在肺癌患者中观察到三种免疫图模式:T细胞丰富型、T细胞贫乏型和中间型。
  • T细胞丰富型以肿瘤中丰富T细胞、调节性T细胞、髓源性抑制细胞、检查点分子和免疫抑制分子的基因特征为特点,提示存在被免疫抑制微环境抑制的抗肿瘤免疫。
  • T细胞贫乏型反映肿瘤中缺乏抗肿瘤免疫、树突状细胞活化不充分和抗原提呈不足。
  • 腺癌患者和非腺癌患者的免疫图均包括T细胞丰富型和T细胞贫乏型,提示组织学类型不一定反映肿瘤的癌症免疫状态。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The interaction of immune cells and cancer cells shapes the immunosuppressive tumor microenvironment. For successful cancer immunotherapy, comprehensive knowledge of antitumor immunity as a dynamic spatiotemporal process is required for each individual patient. To this end, we developed an immunogram for the cancer-immunity cycle by using next-generation sequencing. METHODS: Whole exome sequencing and RNA sequencing were performed in 20 patients with NSCLC (12 with adenocarcinoma, seven with squamous cell carcinoma, and one with large cell neuroendocrine carcinoma). Mutated neoantigens and cancer germline antigens expressed in the tumor were assessed for predicted binding to patients' human leukocyte antigen molecules. The expression of genes related to cancer immunity was assessed and normalized to construct a radar chart composed of eight axes reflecting seven steps in the cancer-immunity cycle. RESULTS: Three immunogram patterns were observed in patients with lung cancer: T-cell-rich, T-cell-poor, and intermediate. The T-cell-rich pattern was characterized by gene signatures of abundant T cells, regulatory T cells, myeloid-derived suppressor cells, checkpoint molecules, and immune-inhibitory molecules in the tumor, suggesting the presence of antitumor immunity dampened by an immunosuppressive microenvironment. The T-cell-poor phenotype reflected lack of antitumor immunity, inadequate dendritic cell activation, and insufficient antigen presentation in the tumor. Immunograms for both the patients with adenocarcinoma and the patients with nonadenocarcinoma tumors included both T-cell-rich and T-cell-poor phenotypes, suggesting that histologic type does not necessarily reflect the cancer immunity status of the tumor. CONCLUSIONS: The patient-specific landscape of the tumor microenvironment can be appreciated by using immunograms as integrated biomarkers, which may thus become a valuable resource for optimal personalized immunotherapy.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Karasaki T, Nagayama K, Kuwano H, et al. An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer. J Thorac Oncol. 2017. PMID: 28088513. doi:10.1016/j.jtho.2017.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。